top of page

Supported projects
Prostperia
Is marketing a new generation of cancer screening tests, particularly for prostate cancer, based on a personalized “in silico” approach. By combining in-vitro biological data with the patient's personal information, these accessible, non-invasive tests enable a more accurate risk assessment and referral to complementary examinations, such as ultrasound, for an early, personalized diagnosis.
PSCC's entrance
December 2023
Localization
FR - Grand Est
Modality
DM/DiV
Development status
Medtech – Market (CE IVDD)
Award(s)
bottom of page

